Plain-English translation of NCT05663515 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Pancreatic Cancer research guide →EXCEED is a large safety study that examines whether , a medication used to treat type 2 diabetes, might be linked to pancreatic cancer. Researchers will compare medical records from patients across seven European countries who started taking this medication with those who started taking other diabetes medications, to see if there are any differences in cancer risk between the two groups.
When new medications are approved, doctors and regulators want to continue watching for any safety concerns that might not have been caught during initial testing. This study helps answer an important question: is the medication as safe as we believe it to be?
You likely qualify if…
You likely don't qualify if…
This is not a traditional clinical trial where you receive a new treatment. Instead, researchers will use your existing medical records from your doctor's office or health insurance company to track your health over time. You won't need to visit a study site or take any new medications—the study simply uses information that has already been collected about your diabetes care and any health diagnoses you may have received.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
Denmark
Finland
France
Norway
Spain